Medicare Enrolled
Dr. Sean Wollaston, M.D.
Optician · North Hollywood, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wollaston from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wollaston?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wollaston
Dr. Sean Wollaston is an optician specialist in North Hollywood, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wollaston performed 310,490 Medicare services across 1,883 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wollaston received a total of $23,221 from 57 pharmaceutical and/or device companies across 1011 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wollaston is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in CA
$23,221 industry payments
Medicare Practice Summary
Medicare Utilization ↗310,490
Medicare services
Top 0% in CA for optician
1,883
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15,524 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
140,400 | $4 | $12 |
| Tocilizumab injection (Actemra) | 91,720 | $4 | $7 |
| Romosozumab injection (Evenity) for osteoporosis | 43,260 | $8 | $11 |
| Denosumab injection (Prolia/Xgeva) | 24,420 | $17 | $33 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
4,010 | $18 | $112 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,966 | $108 | $270 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
1,456 | $64 | $189 |
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
1,120 | $13 | $43 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
830 | $8 | $20 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
292 | $118 | $345 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
290 | $0 | $1 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
136 | $9 | $40 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
114 | $88 | $237 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
105 | $26 | $110 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
101 | $133 | $415 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
50 | $142 | $364 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $12 | $64 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
33 | $23 | $65 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
27 | $73 | $184 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $77 | $184 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
24 | $31 | $78 |
| New patient office visit, complex (60-74 min) | 21 | $188 | $521 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
20 | $48 | $150 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
20 | $50 | $155 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
97.5% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,221
Total received (2018-2024)
Avg $3,317/year across 7 years
Top 8% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,011
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,179 (95.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$977 (4.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,538
2023
$2,916
2022
$4,366
2021
$2,595
2020
$3,300
2019
$3,476
2018
$3,031
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,102
ABBVIE INC.
$677
Janssen Biotech, Inc.
$411
Novartis Pharmaceuticals Corporation
$388
PFIZER INC.
$238
Radius Health, Inc.
$190
UCB, Inc.
$158
AstraZeneca Pharmaceuticals LP
$119
Boehringer Ingelheim Pharmaceuticals, Inc.
$107
GlaxoSmithKline, LLC.
$54
ANI Pharmaceuticals, Inc.
$35
Organon Llc
$25
Genentech USA, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$16
Top 3 companies account for 61.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$8,426
Janssen Biotech, Inc.
$2,065
ABBVIE INC.
$1,558
AbbVie Inc.
$1,262
Novartis Pharmaceuticals Corporation
$1,177
GENZYME CORPORATION
$715
PFIZER INC.
$684
AbbVie, Inc.
$660
GlaxoSmithKline, LLC.
$655
Horizon Therapeutics plc
$610
E.R. Squibb & Sons, L.L.C.
$549
UCB, Inc.
$493
Flexion Therapeutics, Inc.
$444
AstraZeneca Pharmaceuticals LP
$408
Radius Health, Inc.
$362
Lilly USA, LLC
$318
Celgene Corporation
$271
NOVARTIS PHARMACEUTICALS CORPORATION
$264
Boehringer Ingelheim Pharmaceuticals, Inc.
$251
Genentech USA, Inc.
$186
Merck Sharp & Dohme Corporation
$163
Pacira Therapeutics, Inc.
$160
Mallinckrodt Hospital Products Inc.
$137
Mallinckrodt LLC
$137
Fresenius Kabi USA, LLC
$98
Eisai Inc.
$96
Organon LLC
$71
FIDIA PHARMA USA INC.
$70
MEDAC PHARMA, INC.
$70
Celltrion USA Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$62
Bioventus LLC
$56
Alexion Pharmaceuticals, Inc.
$52
Fidia Pharma USA Inc.
$49
Stryker Corporation
$46
TerSera Therapeutics LLC
$46
DePuy Synthes Sales Inc.
$40
Teva Pharmaceuticals USA, Inc.
$36
ANI Pharmaceuticals, Inc.
$35
Kowa Pharmaceuticals America, Inc.
$29
Regeneron Healthcare Solutions, Inc.
$28
Kiniksa Pharmaceuticals, Ltd.
$27
Organon Llc
$25
Bayer HealthCare Pharmaceuticals Inc.
$24
Mallinckrodt Enterprises LLC
$24
Zimmer Biomet Holdings, Inc.
$22
Avanos Medical
$22
Aurinia Pharma U.S., Inc.
$21
Gilead Sciences, Inc.
$20
West-Ward Pharmaceuticals
$19
Octapharma USA, Inc.
$19
Boston Scientific Corporation
$19
Sobi, Inc
$19
Horizon Pharma plc
$18
EUSA Pharma (US) LLC
$15
Vertiflex, Inc.
$14
Medtronic USA, Inc.
$11
Top 3 companies account for 51.9% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ACTHAR · AMJEVITA · AVSOLA · Actemra · Adempas · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUPIXENT · Dayvigo · Durolane · EVENITY · Enbrel · FORTEO · Gel-One Cross-linked Hyaluronate · HADLIMA · HUMIRA · HYALGAN · HYMOVIS · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SUPERION · Seglentis · Strensiq · Superion ISS · Sylvant · TALTZ · TARGETSTIM · TAVNEOS · TREMFYA · TRIVISC SODIUM HYALURONATE · Trintellix · Truxima · Tymlos · ULTOMIRIS · Uloric · XELJANZ · YUFLYMA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in CA.
Geographic Context
Opticians within 10 mi
1,387
Per 100K population
14.1
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wollaston is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wollaston experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Wollaston performed 140,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wollaston receive payments from pharmaceutical companies?
Yes. Dr. Wollaston received a total of $23,221 from 57 companies across 1,011 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wollaston's costs compare to other opticians in North Hollywood?
Dr. Wollaston's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wollaston) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in North Hollywood
Browse opticians in North Hollywood ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology